Page 256 - Multidisipliner Covid 19
P. 256

BÖLÜM  14






          KAYNAKLAR


          1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology
             of 2019 novel coronavirus: implications for virus origins and receptor
             binding. www.thelancet.com. 2020;395:565. doi:10.1016/S0140-6736(20)
             30251-8
          2. Yeşilbağ K, Aytoğu G. Coronavirus Host Divergence and Novel Coro-
             navirus (Sars-CoV-2) Outbreak. Clin Exp Ocul Trauma Infect. 2020;2(1):6-
             14.
          3. Kalita P, Padhi AK, Zhang KYJ, Tripathi T. Design of a peptide-based
             subunit vaccine against novel coronavirus SARS-CoV-2. Microb Pathog.
             2020;145:104236. doi:10.1016/j.micpath.2020.104236
          4.  Hulswit RJG, De Haan CAM, Bosch B-J. Coronavirus Spike Protein
             and Tropism Changes. doi:10.1016/bs.aivir.2016.08.004
          5.  Payne S. Family Coronaviridae. In: Viruses: From Understanding to
             Investigation. 1st ed. United Kingdom: Academic Press; 2017:149-158.
             doi:10.1016/B978-0-12-803109-4.00017-9
          6.  Tai W, He L, Zhang X, et al. Characterization of the receptor-binding
             domain (RBD) of 2019 novel coronavirus: implication for development
             of RBD protein as a viral attachment inhibitor and vaccine. doi:10.1038/
             s41423-020-0400-4
          7. Letko M, Marzi A, Munster V. Functional assessment of cell entry and
             receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.
             Nat Microbiol. 2020;5(4):562-569. doi:10.1038/s41564-020-0688-y
          8. Coronavirus Disease (COVID-19) Situation Report-154.; 2020.
          9.  World Health Organization. DRAFT Landscape of COVID-19 Candidate
             Vaccines –20 April 2020.; 2020. https://www.who.int/blueprint/priority-
             diseases/key-action/novel-coronavirus-landscape-ncov.pdf. Accessed
             June 1, 2020.
          10. Checcucci E, Piramide F, Pecoraro A, et al. The vaccine journey for
             COVID-19: a comprehensive systematic review of current clinical trials
             in humans. Panminerva Med. May 2020. doi:10.23736/S0031-0808.20.
             03958-0
          11.  World Health Organization (WHO). List of Candidate Vaccines Developed
             against SARS-CoV.; 2020. https://www.who.int/blueprint/priority-
             diseases/key-action/list-of-candidate-vaccines-developed-against-
             sars.pdf?ua=1. Accessed June 18, 2020.




                                                                        255
   251   252   253   254   255   256   257   258   259   260   261